-- 週一，New Found Gold (NFG.V) 在美國盤前交易中上漲 1.6%，此前該公司宣布了一項 2.05 億美元的融資方案，其中包括一項由 EdgePoint Investment Group 和基石投資者 Eric Sprott 領投的 1 億美元包銷股票融資，以及一項與 EdgePoint 達成的 1.05 億美元高級信貸安排。 該公司在聲明中表示，所得款項將用於推進位於紐芬蘭的 Queensway 金礦計畫。 該公司將以每股 2.96 美元的價格發行 3,380 萬股股票，籌集 1 億美元。承銷商也被授予 15% 的超額配售選擇權。 New Found Gold 也與 EdgePoint 達成了最高 1.05 億美元的擔保信貸安排。資金將分兩期發放：7,000 萬美元和 3,500 萬美元。兩期資金將在滿足特定條件後發放。 作為回報，New Found Gold將向EdgePoint發行總額為900萬美元的不可轉讓的股票認股權證：第一期發行價值600萬美元的認股權證，可按每股3.30美元的價格認購250萬股股票；第二期發行價值300萬美元的認股權證，可以多倫多證券交易銷售股票交易股票價格認值（TSX Venture25%）。 New Found Gold表示，這筆2.05億美元的融資方案涵蓋了其旗艦項目Queensway黃金項目一期投產所需的初始資本支出。該公司還表示，將不再推進3月初宣布的與Nebari Natural Resources Credit Fund II的7,500萬美元擔保貸款和認股權證發行計畫。 週五，New Found Gold在多倫多證券交易所創業板收盤上漲0.09美元，漲幅3.1%，報2.96美元。
Related Articles
Australia
Exelon Seen Offsetting PECO Rate Case Withdrawal Impact Over Time, RBC Says
Exelon (EXC) will eventually be able to offset the negative impact on revenue of the withdrawal of rate cases by its Pennsylvania-based energy utility subsidiary PECO, RBC Capital Markets said.The subsidiary withdrew its electric and gas rate cases with the Pennsylvania Public Utility Commission, which were requests for a $429 million electric revenue increase and an $81 million gas increase, the brokerage said in a Friday note.They estimate that PECO will miss about $130 million to $200 million in incremental revenue, translating to a negative impact of about $0.09 to $0.14 on earnings per share in 2027.Exelon will be able to mitigate the drag through new rate hike requests, managing operations and maintenance costs, and an accelerated capital plan company-wide.The investment firm noted that Exelon maintained its 2026 adjusted EPS guidance of $2.81 to $2.91 and expressed confidence in its ability to achieve the high end of its annual EPS growth target of 5% to 7% through 2029.BC maintained its sector-perform rating on the stock and lowered its price target to $48 from $51.Price: $47.18, Change: $+0.15, Percent Change: +0.33%
$EXC
Australia
Pfizer's Upcoming Tafamidis Bench Trial Shows Asymmetric Upside, RBC Capital Markets Says
Pfizer's (PFE) tafamidis bench trial commencing next week shows an asymmetric upside based on modeling of three core outcome scenarios, creating a $5 billion net present value differential between bear and bull cases, RBC Capital Markets said in a Monday note.The investment firm said the lawsuit hinges on the '441 polymorph patent that is set to expire in 2035 and is "scientifically the weakest," as the '695 compound and '696 method-of-use patents are expected to hold.RBC estimated a 19% probability for a Pfizer win, with the company showing infringement and getting protection through 2035, representing over $6 billion in net present value.There is a 60% probability for a tie, with generics entry from around 2032, representing net present value of over $3 billion, according to the note.Additionally, there's a 21% probability for Pfizer losing the case and its polymorph patent is held as not infringed, translating into 2028 entry of generics, which is currently priced in the company's stock, the firm said.RBC maintained its underperform rating on the stock with a $25 price target.Price: $27.77, Change: $+0.21, Percent Change: +0.74%
$PFE
Japan
US Equity Indexes Retreat From Records as Iran Peace Talks Hang in Balance
US equity indexes slipped, while crude oil futures rose amid high-stakes Middle East diplomacy to bring Iran back to the negotiating table in Pakistan for a second round of peace talks.The Nasdaq Composite fell 0.6% to 24,308.2, with the S&P 500 down 0.4% to 7,100.3, after breaking records last week when President Donald Trump talked up the likelihood of reaching an Iran peace deal before the end of the current, two-week ceasefire on Tuesday. The Dow Jones Industrial Average fell 0.3% to 49,284.5.Consumer discretionary, communication services, and technology led decliners intraday. Energy and materials were among the biggest gainers.West Texas Intermediate crude oil futures jumped 5.1% to $88.16, and Brent crude futures advanced 5% to $94.91.Vice President JD Vance and top US officials are expected to depart Tuesday for Islamabad, Pakistan, ahead of a potential second round of talks with Iran, CNN reported Monday, citing sources. Iran is considering attending peace talks, a senior official from the Middle East nation told Reuters on Monday, following moves by Islamabad to end a US blockade of Tehran's ports, a major hurdle for the country under threat of widespread attack to rejoin peace efforts.Trump said it's "highly unlikely" he would extend the two-week ceasefire with Iran if a deal is not reached before it ends, and said the Strait of Hormuz would remain blocked until an agreement is finalized, Bloomberg reported. The US president said in a Monday phone interview that the second round of talks with Iran is set to begin Tuesday.
$^DJI$^IXIC$^SPX